Hepatitis C seems to progress more rapidly in Latinos than in people from other racial and ethnic groups. However, in the clinical trials of Sovaldi there was no apparent difference in success rates with the drug among Latinos than among non-Latinos.

Click here to read more about race and hepatitis C.